Claybrook Capital’s Colgate-Palmolive CL Stock Holding History

Claybrook Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100	Closed	-$14K	–	194
2017 Q4	$14K	Buy	+100	New	+$7.3K	0.01%	147

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Claybrook Capital's CL Position: Q4 2022 in Review

Claybrook Capital sold out of Colgate-Palmolive (CL) in Q4 2022, closing a stake of 3,300 shares — an estimated $232K sold.

Claybrook Capital first reported a position in CL in Q4 2017 and held it in 20 quarters. The position peaked at $1.79M in Q4 2018. 1,699 funds tracked by Wall St. Rank hold CL as of Q4 2022.

Claybrook Capital reported no remaining Colgate-Palmolive position as of Q4 2022 after selling out during the quarter.
Claybrook Capital sold 3,300 Colgate-Palmolive shares in Q4 2022, an estimated $232K.
Claybrook Capital first reported a position in Colgate-Palmolive in Q4 2017 and held it in 20 quarters.
Claybrook Capital's Colgate-Palmolive position peaked at $1.79M in Q4 2018.
1,699 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2022.

Based on Claybrook Capital's 13F filing for Q4 2022, filed 24 Jan 2023.